GalenusRx
PrivateLast Round
Grant
Oct 17, 2025
Total Funding Raised
$9.88M
Momentum Score
50 /100
Company Overview
GalenusRx is a healthcare technology company that provides a medication safety platform, APPRAISE, which analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to provide a comprehensive risk assessment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Precision Medicine, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GalenusRx Comps
Public and private peers based on sector, stage, and business model.
GalenusRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 17, 2025 | ||||
| Series A | Jul 17, 2024 |
Key People
Founding team and executive leadership
GalenusRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 114% MoM.
- Apr 23, 2025
Bryan Rotella appointed to the Advisory Board.
GalenusRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GalenusRx's valuation, stock price, and market status.
